Skip to main content

Nicholas Westfall

Equibles does not estimate personal net worth.

About Nicholas Westfall

Earlier roles on record: CEO at Chemed Corp (CHE) until July 29, 2025. Chemed Corp reported in an 8-K filed July 29, 2025 that Nicholas Westfall resigned as Chairman and Chief Executive Officer of Vitas, effective July 29, 2025. Nicholas Westfall has spoken on 4 earnings calls across 1 company, most recently for Chemed Corp on April 24, 2024. The companies whose calls Nicholas Westfall spoke on are classified in the Healthcare sector.

“Nicholas M. Westfall, Executive Vice President of Chemed Corporation (the "Company") and Chairman and Chief Executive Officer of Vitas, advised that he is resigning as Chairman and Chief Executive Officer of Vitas effective as of July 29, 2025, to pursue other interests.”
Chemed Corp Form 8-K, filed July 29, 2025 · Read the filing

Nicholas Westfall on recent calls

“I'm very pleased with our continued sustainable expansion of our workforce and patient capacity through the first quarter of 2024. As Kevin mentioned, we expanded our bedside headcount by 173 licensed professionals during the quarter.”
CEO, Chemed Corp Q1 FY2024 Earnings Call ·
“As Kevin discussed, we implemented a targeted retention hiring bonus program at VITAS effective July 1 of 2022. This program was focused on licensed nurses, including admission nurses, nurse managers, home health aides, and social workers.”
CEO, Chemed Corp Q2 FY2023 Earnings Call ·
“As we've mentioned in the past, we implemented a targeted hiring and retention bonus program at VITAS, effective July 1, 2022. This program is focused on licensed nurses, nurse managers, home health aides, and social workers.”
CEO, Chemed Corp Q1 FY2023 Earnings Call ·
“Before I discuss our second quarter metrics, I want to reiterate Kevin's earlier comment and thank all of our VITAS team members for their continued perseverance throughout this pandemic.”
CEO, Chemed Corp Q2 FY2020 Earnings Call ·

Affiliation history

Company network

Recent activity